410 related articles for article (PubMed ID: 21322080)
21. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B
Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718
[TBL] [Abstract][Full Text] [Related]
22. Reduced-rank hazard regression for modelling non-proportional hazards.
Perperoglou A; le Cessie S; van Houwelingen HC
Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
[TBL] [Abstract][Full Text] [Related]
23. Measuring comorbidity in patients with head and neck cancer.
Hall SF; Rochon PA; Streiner DL; Paszat LF; Groome PA; Rohland SL
Laryngoscope; 2002 Nov; 112(11):1988-96. PubMed ID: 12439168
[TBL] [Abstract][Full Text] [Related]
24. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
[TBL] [Abstract][Full Text] [Related]
25. Results of a surgical resection of pulmonary metastasis from malignant head and neck tumor.
Haro A; Yano T; Yoshida T; Ito K; Morodomi Y; Shoji F; Nakashima T; Maehara Y
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):700-3. PubMed ID: 20123888
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
27. Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases.
Le Tourneau C; Velten M; Jung GM; Bronner G; Flesch H; Borel C
Head Neck; 2005 Sep; 27(9):801-8. PubMed ID: 16086415
[TBL] [Abstract][Full Text] [Related]
28. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.
Preuss SF; Dinh V; Klussmann JP; Semrau R; Mueller RP; Guntinas-Lichius O
Oral Oncol; 2007 Apr; 43(4):402-7. PubMed ID: 17071133
[TBL] [Abstract][Full Text] [Related]
29. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
[TBL] [Abstract][Full Text] [Related]
30. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
[TBL] [Abstract][Full Text] [Related]
31. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck.
Pytynia KB; Grant JR; Etzel CJ; Roberts DB; Wei Q; Sturgis EM
J Clin Oncol; 2004 Oct; 22(19):3981-8. PubMed ID: 15459221
[TBL] [Abstract][Full Text] [Related]
32. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy.
Doweck I; Denys D; Robbins KT
Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
34. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer.
van Bokhorst-de van der Schuer ; van Leeuwen PA; Kuik DJ; Klop WM; Sauerwein HP; Snow GB; Quak JJ
Cancer; 1999 Aug; 86(3):519-27. PubMed ID: 10430262
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in head and neck squamous cell carcinoma: comparison of CHAID decision trees technology and Cox analysis.
Avilés-Jurado FX; León X
Head Neck; 2013 Jun; 35(6):877-83. PubMed ID: 22711263
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
37. Which model is better in predicting the survival of laryngeal squamous cell carcinoma?: Comparison of the random survival forest based on machine learning algorithms to Cox regression: analyses based on SEER database.
Sun H; Wu S; Li S; Jiang X
Medicine (Baltimore); 2023 Mar; 102(10):e33144. PubMed ID: 36897699
[TBL] [Abstract][Full Text] [Related]
38. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
[TBL] [Abstract][Full Text] [Related]
39. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users.
Gillespie MB; Moody MW; Lee FS; Poole LJ; Hornig JD; Lathers D; Young MR; Day TA
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):28-31. PubMed ID: 17224518
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
